AVI Biopharma, Inc. (AVII) Reports In-Line Q4 EPS

March 10, 2011 4:02 PM EST
Get Alerts AVII Hot Sheet
Price: $0.66 --0%

Financial Fact:
Operating loss: -56.53M

Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
AVI Biopharma, Inc. (NASDAQ: AVII) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $15.5 million versus the consensus estimate of $11.65 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings